-
Posted by
Two Blokes May 25, 2025 -
Filed in
Stock
-
5 views
Medicus Pharma (NASDAQ:MDCX) CEO Raza Bokhari talked with Proactive about the company's newly announced regulatory approval to expand its Phase 2 trial into the United Arab Emirates. The study is focused on a noninvasive therapy for basal cell carcinoma (BCC), the most common form of cancer globally.
